Poland· PL-100534155
Aqneursa
A medicinal product containing levacetylleucine, registered in Poland by IntraBio Ireland Limited.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Levacetylleucine
- Manufacturer
- IntraBio Ireland Limited
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Levacetylleucine in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAQNEURSAIntraBio Inc
- FinlandAqneursaIntrabio Ireland Limited
- CzechiaAQNEURSAIntraBio Ireland Ltd., Dublin 2
- IrelandAqneursa 1 g granules for oral suspension in sachetIntrabio Ireland Limited
- BelgiumAqneursa 1 gIntraBio Ireland Limited
- NetherlandsAqneursa 1 g granulaat voor orale suspensie in sachetIntrabio Ireland Limited
- SwedenAqneursa 1 g Granulat till oral lösning i dospåseIntrabio Ireland Limited
- IcelandAqneursaIntrabio Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Aqneursa
- Liechtenstein · Aqneursa
- Norway · Aqneursa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/deb98ad5-5b20-4ab3-8b78-c236937e0579 GET /v1/drugs/deb98ad5-5b20-4ab3-8b78-c236937e0579?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Granulat do sporządzania zawiesiny doustnej w saszetce",
"source": "urpl",
"strength": "1 g",
"packaging": "Rp ¦ EU/1/25/1928/001 ¦ 166078\n28 saszetek \nRp ¦ EU/1/25/1928/002 ¦ 166079\n112 saszetek",
"substance": "Lewacetyloleucyna 1 g",
"common_name": "Levacetylleucine",
"pl_product_id": "100534155",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about levacetylleucine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.